Alzheimer Disease
Affiris Begins Clinical Testing of Alzheimer's Vaccine
Published in Hospital Business Week, August 5th, 2007
The Alzheimer's vaccine known as Affitope AD01 from Affiris has now entered the clinical phase of its development and is now being tested on humans for the first time. This development means that the 8.5 million-Euro venture capital finance agreement the company concluded with Munich-based MIG-Fonds in April 2006 has reached a key milestone on schedule. Up to 24 Alzheimer's patients are to be vaccinated, with the aim of this initial phase I trial being to demonstrate the vaccine's safety and its suitability for human use.
Affiris GmbH, based in Vienna, Austria, announced the start of a phase I clinical trial for its Alzheimer's vaccine, Affitope AD01. The vaccine is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Adverse Drug Reactions
Fauquier Health System Leading the Country in Addressing Nation's $13 Billion Patient Drug Error Challenge Using New Automation - Aflac Incorporated
Just Duckin' In - AHS; AAFP; Pfizer Animal Health
Dr. Jane Brunt Named 2008 AAFP KNOW Heartworms Spokesperson - Akorn, Inc.
Akorn, Inc. Signs Exclusive Development and Supply Agreement with Haemonetics Corporation for Three Premix Products - Allscripts
Tennessee Health Information Services Co-Operative Selects Allscripts Electronic Health Record - AMICAS, Inc.
AMICAS Expands Market Presence with 14 New Contracts in Q2 2007 - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
